Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG432555 Inhibitors

EG432555 inhibitors are a class of chemical compounds characterized by their ability to selectively inhibit the activity of the target enzyme EG432555. These inhibitors often possess a core structure that interacts specifically with the active site of the enzyme, leading to effective blockage of its catalytic functions. The structure-activity relationship (SAR) is a critical aspect of these molecules, as minor modifications in the chemical scaffolding can significantly alter binding affinity and specificity. Typically, these inhibitors have complex aromatic or heterocyclic core structures, which are modified with various functional groups to enhance their chemical stability, solubility, and ability to penetrate cellular membranes. Such modifications are essential in optimizing these molecules to achieve a fine balance between potency and selectivity. This precision in structural design ensures that EG432555 inhibitors are highly effective in binding to their intended targets while minimizing non-specific interactions with other proteins.

Chemically, EG432555 inhibitors often exhibit key features like hydrogen bond donors or acceptors, hydrophobic moieties, and other substituents that facilitate strong binding within the enzyme's binding pocket. Many of these inhibitors also contain flexible linkers that allow for a dynamic interaction with the enzyme, adjusting conformation for optimal fit. The diversity of the functional groups attached to the core structure enables fine-tuning of physicochemical properties like molecular weight, lipophilicity, and pKa, which can impact the behavior of the inhibitor under different experimental conditions. The synthesis of EG432555 inhibitors often employs advanced organic chemistry techniques such as cross-coupling reactions, amide bond formation, and regioselective substitutions. This meticulous approach in both design and synthesis allows for the exploration of a broad range of derivatives, each exhibiting a unique profile in terms of binding efficiency, metabolic stability, and interaction with biological systems.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Inhibitor of GTPase activity. Brefeldin A disrupts vesicular transport and Golgi function, indirectly impacting Gm5431 by inhibiting its predicted GTPase activity. This leads to altered cellular response to interferon-beta and defense response.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Rho-associated protein kinase (ROCK) inhibitor affecting GTPase activity. Y-27632 indirectly modulates Gm5431 by influencing the Rho GTPase pathway, potentially altering the cellular response to interferon-beta and defense response.

SecinH3

853625-60-2sc-203260
5 mg
$278.00
6
(1)

ARF guanine nucleotide exchange factor (GEF) inhibitor. SecinH3 indirectly inhibits Gm5431 by disrupting ARF GEF activity, potentially impacting cellular response to interferon-beta and defense response.

Simvastatin

79902-63-9sc-200829
sc-200829A
sc-200829B
sc-200829C
50 mg
250 mg
1 g
5 g
$31.00
$89.00
$135.00
$443.00
13
(1)

HMG-CoA reductase inhibitor affecting GTPase activity. Simvastatin indirectly influences Gm5431 by modulating the mevalonate pathway, potentially altering the cellular response to interferon-beta and defense response.

CCG-1423

285986-88-1sc-205241
sc-205241A
1 mg
5 mg
$30.00
$90.00
8
(1)

Rho/MRTF/SRF pathway inhibitor. CCG-1423 indirectly influences Gm5431 by impacting the Rho/MRTF/SRF pathway, potentially altering the cellular response to interferon-beta and defense response.

FK-506

104987-11-3sc-24649
sc-24649A
5 mg
10 mg
$78.00
$151.00
9
(1)

Calcineurin inhibitor. FK506 indirectly affects Gm5431 by modulating calcineurin activity, potentially impacting the cellular response to interferon-beta and defense response.

Farnesyl thiosalicylic acid

162520-00-5sc-205322
sc-205322A
1 mg
5 mg
$61.00
$82.00
15
(1)

Ras inhibitor affecting GTPase activity. Salirasib indirectly influences Gm5431 by modulating Ras activity, potentially altering the cellular response to interferon-beta and defense response.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$219.00
$634.00
5
(1)

Farnesyltransferase inhibitor. Manumycin A indirectly affects Gm5431 by disrupting protein farnesylation, potentially altering the cellular response to interferon-beta and defense response.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor. SB203580 indirectly influences Gm5431 by modulating the p38 MAPK pathway, potentially altering the cellular response to interferon-beta and defense response.

Thiazovivin

1226056-71-8sc-361380
sc-361380A
10 mg
25 mg
$284.00
$634.00
15
(1)

Rho-associated protein kinase (ROCK) inhibitor affecting GTPase activity. Thiazovivin indirectly modulates Gm5431 by influencing the Rho GTPase pathway, potentially altering the cellular response to interferon-beta and defense response.